You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|
|---|---|
| Published in |
New England Journal of Medicine, December 2015
|
| DOI | 10.1056/nejmoa1509388 |
| Pubmed ID | |
| Authors |
Jan A Burger, Alessandra Tedeschi, Paul M Barr, Tadeusz Robak, Carolyn Owen, Paolo Ghia, Osnat Bairey, Peter Hillmen, Nancy L Bartlett, Jianyong Li, David Simpson, Sebastian Grosicki, Stephen Devereux, Helen McCarthy, Steven Coutre, Hang Quach, Gianluca Gaidano, Zvenyslava Maslyak, Don A Stevens, Ann Janssens, Fritz Offner, Jiří Mayer, Michael O'Dwyer, Andrzej Hellmann, Anna Schuh, Tanya Siddiqi, Aaron Polliack, Constantine S Tam, Deepali Suri, Mei Cheng, Fong Clow, Lori Styles, Danelle F James, Thomas J Kipps |
X Demographics
The data shown below were collected from the profiles of 100 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 37 | 37% |
| United Kingdom | 5 | 5% |
| Spain | 4 | 4% |
| Venezuela, Bolivarian Republic of | 3 | 3% |
| Japan | 2 | 2% |
| Saudi Arabia | 2 | 2% |
| India | 2 | 2% |
| France | 2 | 2% |
| Canada | 2 | 2% |
| Other | 9 | 9% |
| Unknown | 32 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 62 | 62% |
| Practitioners (doctors, other healthcare professionals) | 19 | 19% |
| Scientists | 18 | 18% |
| Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 766 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | <1% |
| United States | 3 | <1% |
| France | 2 | <1% |
| Turkey | 1 | <1% |
| India | 1 | <1% |
| Germany | 1 | <1% |
| Japan | 1 | <1% |
| Ecuador | 1 | <1% |
| Unknown | 753 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 93 | 12% |
| Researcher | 89 | 12% |
| Student > Master | 81 | 11% |
| Student > Ph. D. Student | 75 | 10% |
| Student > Bachelor | 68 | 9% |
| Other | 153 | 20% |
| Unknown | 207 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 304 | 40% |
| Biochemistry, Genetics and Molecular Biology | 55 | 7% |
| Agricultural and Biological Sciences | 53 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 35 | 5% |
| Immunology and Microbiology | 17 | 2% |
| Other | 76 | 10% |
| Unknown | 226 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 988. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2024.
All research outputs
#16,899
of 25,874,560 outputs
Outputs from New England Journal of Medicine
#732
of 32,725 outputs
Outputs of similar age
#154
of 397,137 outputs
Outputs of similar age from New England Journal of Medicine
#4
of 349 outputs
Altmetric has tracked 25,874,560 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,725 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 123.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 397,137 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 349 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.